Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Different Rate Control Therapies in Permanent Atrial Fibrillation: A Prospective, Randomised, Open-label, Blinded Endpoint Feasibility Pilot Comparing Digoxin and Beta-blockers as Initial Rate Control Therapy

NCT02391337 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT02391337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02391337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Different Rate Control Therapies in Permanent Atrial Fibrillation: A Prospective, Randomised, Open-label, Blinded Endpoint Feasibility Pilot Comparing Digoxin and Beta-blockers as Initial Rate Control Therapy
Lead sponsor
University of Birmingham
Phase
Phase 4
Overall status
Completed
Start date
December 20, 2016
Completion date
September 16, 2019
Enrollment
161 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

permanent atrial fibrillation